EDOM approval to Sharon Bio-Medicine’s Taloja API plant
Sharon Bio-Medicine Ltd has announced that the company’s active pharmaceutical ingredient (API) manufacturing plant at Talojo, Maharashtra has been approved by European Directorate for the Quality of Medicines & Healthcare (EDQM) council of Europe. Sharon Bio-Medicine Limited is a fast growing Indian Pharmaceutical company. It is involved in manufacturing of intermediates, active pharmaceutical ingredients and finished dosage form. The company also has a division operating under the name SA-FORD, which is OECD GLP certified, specialized in pre-clinical and toxicology studies on animals.
The plant is approved for complying with the certificate of suitability, as well as the implementation of a suitable Quality Management System based on the Good Manufacturing Practice as laid down in the EU Rules governing Medicinal Product in the European Union. This EDOM approval is expected to further increase Sharon Bio-Medicine’s sales in Europe and other countries in near future.